Logo image of TECH

BIO-TECHNE CORP (TECH) Stock Price, Quote, News and Overview

NASDAQ:TECH - Nasdaq - US09073M1045 - Common Stock - Currency: USD

76.91  -1.8 (-2.29%)

After market: 78.56 +1.65 (+2.15%)

TECH Quote, Performance and Key Statistics

BIO-TECHNE CORP

NASDAQ:TECH (1/23/2025, 6:39:42 PM)

After market: 78.56 +1.65 (+2.15%)

76.91

-1.8 (-2.29%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High85.57
52 Week Low61.16
Market Cap12.22B
Shares158.89M
Float157.24M
Yearly Dividend0.32
Dividend Yield0.42%
PE42.97
Fwd PE34.35
Earnings (Next)02-04 2025-02-04/amc
IPO02-09 1989-02-09


TECH short term performance overview.The bars show the price performance of TECH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10

TECH long term performance overview.The bars show the price performance of TECH in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 5 -5 -10 -15

The current stock price of TECH is 76.91 USD. In the past month the price increased by 5.11%. In the past year, price increased by 5.89%.

BIO-TECHNE CORP / TECH Daily stock chart

TECH Latest News, Press Releases and Analysis

News Image
9 hours ago - Chartmill

Curious about the S&P500 stocks that are gapping on Thursday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index.

News Image
3 days ago - Bio-Techne Corporation

Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, February 5, 2025,...

News Image
3 days ago - Bio-Techne Corporation

ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio

/PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that BrainChild Bio has been...

TECH Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 26.82 219.88B
DHR DANAHER CORP 33.02 177.44B
A AGILENT TECHNOLOGIES INC 28.82 43.48B
IQV IQVIA HOLDINGS INC 18.97 37.39B
MTD METTLER-TOLEDO INTERNATIONAL 35 28.17B
WST WEST PHARMACEUTICAL SERVICES 50.89 24.91B
WAT WATERS CORP 36.24 24.51B
ILMN ILLUMINA INC 77.9 21.37B
ICLR ICON PLC 14.45 16.73B
RVTY REVVITY INC 26.01 14.97B
AVTR AVANTOR INC 22.32 14.88B
MEDP MEDPACE HOLDINGS INC 30.46 10.81B

About TECH

Company Profile

TECH logo image Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. The company is headquartered in Minneapolis, Minnesota and currently employs 3,100 full-time employees. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.

Company Info

BIO-TECHNE CORP

614 Mckinley Pl N E

Minneapolis MINNESOTA 55413 US

CEO: Charles Kummeth

Employees: 3100

Company Website: https://www.bio-techne.com/

Investor Relations: https://investors.bio-techne.com/

Phone: 16123798854

TECH FAQ

What is the price of TECH?

The current price of TECH is 76.91 USD.


What is the symbol for BIO-TECHNE CORP?

The exchange symbol of BIO-TECHNE CORP is TECH and it is listed on the Nasdaq exchange.


On which exchange is TECH listed?

TECH is listed on the Nasdaq exchange.


Is TECH a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TECH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TECH.


Does TECH pay dividends?

TECH has a dividend yield of 0.42%. The yearly dividend amount is currently 0.32.


When does TECH report earnings?

TECH will report earnings on 2025-02-04, after the market close.


What is the Price/Earnings (PE) ratio of TECH?

The PE ratio for TECH is 42.97. This is based on the reported non-GAAP earnings per share of 1.79 and the current share price of 76.91 USD.


What is the Short Interest ratio of TECH?

The outstanding short interest for TECH is 2.4% of its float.


TECH Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to TECH. When comparing the yearly performance of all stocks, TECH turns out to be only a medium performer in the overall market: it outperformed 64.97% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

TECH Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to TECH. TECH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TECH Financial Highlights

Over the last trailing twelve months TECH reported a non-GAAP Earnings per Share(EPS) of 1.79. The EPS increased by -8.67% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.92%
ROA 7.37%
ROE 9.43%
Debt/Equity 0.14
Chartmill High Growth Momentum
EPS Q2Q%2.44%
Sales Q2Q%4.52%
EPS 1Y (TTM)-8.67%
Revenue 1Y (TTM)26.63%

TECH Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to TECH. The Buy consensus is the average rating of analysts ratings from 22 analysts.

For the next year, analysts expect an EPS growth of 9.84% and a revenue growth 5.58% for TECH


Ownership
Inst Owners100.25%
Ins Owners0.2%
Short Float %2.4%
Short Ratio4.18
Analysts
Analysts82.73
Price Target87.11 (13.26%)
EPS Next Y9.84%
Revenue Next Year5.58%